Which High-Risk Patients Should Get the RSV Vaccine?
While all adults age 75 and up are eligible, here’s who’s considered high risk in the 60-74 group
Related Articles
The Morning After: Huawei launches its Android-free mobile OS
The biggest news stories this morning: Huawei attempts its own mobile OS, Uber tries offering coders for hire, The best Black Friday deals on gaming.
Outsmarting Outages with CallTower Solutions
Discover how CallTower’s reliable UCaaS solutions keep your business connected during outages. Stay productive and seamless—learn more at CallTower today!
Dengue
This JAMA Insights explores several aspects of dengue virus infection, including epidemiology, diagnosis, and clinical management, following a global resurgence in both endemic and nonendemic…
Selection of Patients With Early-Stage Breast Cancer for Extended Endocrine Therapy
This secondary analysis evaluates the ability of a 70-gene expression risk-of-recurrence assay, to identify the patients with early-stage breast cancer who could benefit the most…
Target Serum Urate Achievement and CKD Progression in Patients With Gout and Kidney Disease
This cohort study evaluates the use of urate-lowering therapy to achieve target serum urate levels in patients with gout and stage 3 chronic kidney disease.
Sisters of Charity Health System’s new CEO on the system’s future
The nonprofit has been shifting to a more social services oriented focus.
Flu shot rates outpace Covid vaccines in nursing homes. Here’s why.
New CDC data show that in nursing homes, rates of flu vaccination are far higher than Covid vaccination so far this fall.
Nucleo-cytosolic acetyl-CoA drives tumor immune evasion by regulating PD-L1 in melanoma
Wang et al. report that nucleo-cytosolic acetyl-CoA drives tumor immune evasion by regulating PD-L1 in melanoma. Acetyl-CoA promotes PD-L1 transcription via P300-mediated histone acetylation to suppress…
Magnetic tornado is stirring up the haze at Jupiter’s poles
Dark ovals in Jupiter’s polar haze, visible only at UV wavelengths, were first noticed 25 years ago, then ignored. A UC Berkeley study shows that…
Trump picks Stanford’s Jay Bhattacharya to lead NIH
Bhattacharya would be in charge of Trump’s bold goals to reform the NIH, which spends billions to fund medical research.
